Abstract
Dopaminergic mechanisms play a major role in modulating sexual behavior in humans and animals. Animal data demonstrate important interactions between the dopaminergic and prolactinergic system. As recently demonstrated, dopamine agonists have facilitatory properties for penile erection but may also enhance sexual drive and orgasmic quality. In contrast, chronic elevations of prolactin inhibit appetitive as well as consummatory parameters of sexual behavior. Recent human studies show a marked increase in prolactin after orgasm in males and females. Concerning the biological relevance of acute prolactin alterations after orgasm, prolactin might serve as a neuroendocrine reproductive reflex for peripheral reproductive organs. Alternatively, prolactin may feedback to dopaminergic neurons in the central nervous system and thereby modulate sexual drive and satiation. Here, we provide a brief overview of the physiology of dopamine and prolactin in regulating sexual behavior. In addition, recent experimental and clinical evidence for a postulated feedback mechanism for prolactin and its implications for orgasmic disorders are discussed.
References
Bailey DJ, Dolan AL, Pharoah PD, Herbert J (1984) Role of gonadal and adrenal steroids in the impairment of the male rat’s sexual behaviour by hyperprolactinaemia. Neuroendocrinology 39:555–562
Barbeau A (1969)L-Dopa therapy in Parkinson’s disease: a critical review in nine year’s experience. Can Med Assoc J 101:791–800
Bartke A, Doherty PC, Steger RW, Morgan WW, Amador AG, Herbert DC, Siler-Khodr TM, Smith MS, Klemcke HG, Hymer WC (1984) Effects of estrogen-induced hyperprolactinemia on endocrine and sexual functions in adult male rats. Neuroendocrinology 39:126–135
Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactine (PRL) and its receptor: actions signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Rev 19:225–268
Bowers MBJr, Van Woert M, Davis L (1971) Sexual behavior duringL-dopa treatment for Parkinsonism. Am J Psychiatry 127:1691–1693
Bradley KC, Meisel RL (2001) Sexual behavior induction of c-Fos in the nucleus accumbens and amphetamine-stimulated locomotor activity are sensitized by previous sexual experience in female Syrian hamsters. J Neurosci 21:2123–2130
Buvat J (2003) Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res 15:373–377
Buvat J, Lemaire A, Buvat-Herbaut M, Fourlinnie JC, Racadot A, Fossati P (1985) Hyperprolactinemia and sexual function in men. Hormonal Res 22:196–203
Cannon CM, Palmiter RD (2003) Reward without dopamine. J Neurosci 23:10827–10831
Cebeira M, Hernandez ML, Rodriguez de Fonsesca F, De Miguel R, Fernandez-Ruiz JJ, Ramos JA (1991) Lack of effect of prolactin on the dopaminergic receptor sensitivity of striatal and limbic areas after experimentally-induced alterations in peripheral levels. Life Sci 48:531–541
Chambers RA, Taylor JR, Potenza MN (2003) Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability Am J Psychiatry 160:1041–1052
Chen JC, Ramirez VD (1989) Effects of prolactin on tyrosine hydroxylase activity of central dopaminergic neurons of male rats. Eur J Pharmacol 166:473–479
Cruz-Casallas PE, Nasello AG, Hucke EE, Felicio LF (1999) Dual modulation of male sexual behavior in rats by central prolactin: relationship with in vivo striatal dopaminergic activity. Psychoneuroendocrinology 24:681–693
De Rosa M, Colao A, Di Sarno A, Ferone D, Landi ML, Zarilli S, Paesano L, Merola B, Lombardi G (1998) Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine Eur J Endocrinol 138:286–293
De Rosa M, Zarrilli S, Vitale G, Di Somma C, Orio F, Tauchmanova L, Lombardi G, Colao A (2004) Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. J Clin Endocrinol Metab 89:621–625
DeMaria JE, Lerant AA, Freeman ME (1999) Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats. Brain Res 837:236–241
DeMaria JE, Livingstone JD, Freeman ME (1998) Characterization of the dopaminergic input of the pituitary gland throughout the estrous cycle of the rat. Neuroendocrinology 67:377–383
DeMaria JE, Zelena D, Vecsernyés M, Nagy GM, Freeman ME (1998) The effect of neurointermediate lobe denervation on hypothalamic neuroendocrine dopaminergic neurons. Brain Res 806:89–94
Doherty PC, Bartke A, Smith MS, Davis SL (1985) Increased serum prolactin levels mediate the suppressive effects of ectopic pituitary grafts on copulatory behavior in male rats. Horm Behav 19:111–121
Doherty PC, Baum MJ, Todd RB (1986) Effects of chronic hyperprolactinemia on sexual arousal and erectile function in male rats. Neuroendocrinology 42:368–375
Doherty PC, Lane SJ, Pfeil KA, Morgan WW, Bartke A, Smith MS (1989) Extra-hypothalamic dopamine is not involved in the effects of hyperprolactinemia on male copulatory behavior. Physiol Behav 45:1101–1105
Doherty PC, Wu DE, Matt KS (1990) Hyperprolactinemia preferentially inhibits erectile function in adrenalectomized male rats. Life Sci 47:141–148
Dudley CA, Jamison TS, Moss RL (1982) Inhibition of lordosis behavior in the female rat by intraventricular infusion of prolactin and by chronic hyperprolactinemia. Endocrinology 110:677–679
Erskine MS (1995) Prolactin release after mating and genitosensory stimulation in females. Endocr Rev 16:508–528
Exton MS, Bindert A, Krüger T, Scheller F, Hartmann U, Schedlowski M (1999) Cardiovascular and endocrine alterations after masturbation-induced orgasm in women. Psychosom Med 61:280–289
Exton MS, Krüger THC, Bursch N, Knapp W, Schedlowski M, Hartmann U (2001) Neuroendocrine response to masturbation-induced orgasm following a 3-week sexual abstinence. World J Urol 19:377–382
Exton MS, Krüger THC, Koch M, Paulson E, Knapp W, Hartmann U, Schedlowski M (2001) Coitus-induced orgasm stimulated prolactin secretion in healthy subjects. Psychoneuroendocrinology 26:287–294
Exton NG, Truong TC, Exton MS, Wingenfeld SA, Leygraf N, Saller B, Hartmann U, Schedlowski M (2000) Neuroendocrine response to film-induced sexual arousal in men and women. Psychoneuroendocrinology 25:189–199
Fiorino DF, Coury A, Phillips AG (1997) Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats. J Neurosci 17:4849–4855
Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523–1631
Ganong WF (2000) Circumventricular organs: definition and role in the regulation of endocrine and anatomic function. Clin Exp Pharmacol Physiol 27:422–247
Gitlin M (2003) Sexual dysfunction with psychotropic drugs. Expert Opin Pharamacother 4:2259–2269
Giuliano F, Allard J (2001) Dopamine and sexual function. Int J Imp Res 13:S18-S28
Gonzales-Mora JL, Guadalupe T, Mas M (1990) In vivo voltammetry study of the modulatory action of prolactin on mesolimbic dopaminergic system. Brain Res Bull 25:729–733
Gunnet JW, Freeman ME (1983) The mating-induced release of prolactin: a unique neuroendocrine reponse. Endocr Rev 4:44–61
Haake P, Exton MS, Haverkamp J, Krämer M, Leygraf N, Hartmann U, Schedlowski M, Krüger THC (2002) Absence of orgasm-induced prolactin secretion in a healthy multi-orgasmic male subject. Int J Imp Res 14:133–135
Heaton JPW, Adams MA (2003) Update on central function relevant to sex: remodeling the basis of drug treatments for sex and the brain. Int J Impot Res 15:S25-S32
Heaton JPW (2000) Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine. Neurosci Biobehav Rev 24:561–569
Hernandez ML, Fernandez-Ruiz JJ, Navarro M, De Miguel R, Cebeira M, Vatic S, Ramos JA (1994) Modifications of mesolimbic and nigrostriataldopaminergic activity after intracerebroventricular administration of prolactin. J Neural Trans Gen Sec 96:63–79
Hull EM, Meisel RL, Sachs BD (2002) Male sexual behavior. In: Pfaff DW (ed) Hormones, brain and behavior, vol 1. Academic Press, San Diego, , 3–137
Hummer M, Huber J (2004) Hyperprolactinemia and antipsychotic therapy in schizophrenia. Curr Med Res Opin 20:189–197
Kalra PS, Simpkins JW, Luttge WG, Kalra SP (1983) Effects on male sex behavior and preoptic dopamine neurons of hyperprolactinemia induced by MtTW15 pituitary tumors. Endocrinology 113:2065–2071
Kamel F, Mock EJ, Wright WW, Frankel AI (1975) Alterations in plasma concentrations of testosterone, LH, and prolactin associated with mating in the male rat. Horm Behav 6:277–288
Kooy A, Weber RF, Ooms MP, Vreeburg JT (1988) Deterioration of male sexual behavior in rats by the new prolactin-secreting tumor 7315b. Horm Behav 22:351–361
Krüger T, Exton MS, Pawlak C, Von zur Mühlen A, Hartmann U, Schedlowski M (1998) Neuroendocrine and cardiovascular response to sexual arousal and orgasm in men. Psychoneuroendocrinology 23:401–411
Krüger THC, Haake P, Hartmann U, Schedlowski M, Exton MS (2002) Prolactin release following orgasm: a feedback control of sexual arousal? Neurosci Biobehav Rev 26:31–44
Krüger THC, Hartmann U, Haake P, Chereat D, Knapp W, Janssen OE, Exton MS, Schedlowski M (2003) Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocrinol 177:57–64
Krüger THC, Haake P, Haverkamp J, Krämer M, Exton MS, Saller B, Leygraf N, Hartmann U, Schedlowski M (2003) Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol 179:357–365
Labbate LA, Croft HA, Oleshansky MA (2003) Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 64 [Suppl 10]:11–19
Lal S, Ackman D, Thavundayil JX, Kiely ME, Etienne P (1984) Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects. Prob Neuropsychopharmacol Biol Psychiatry 8:695–699
Lal S, Laryea E, Thavundayil JX, Nair NP, Negrete J, Ackman D, Blundell P, Gardinier RJ (1987) Apomorphine-induced penile tumescence in impotent patients: preliminary findings. Prog Neuro-Psychoph 11:235–242
Lookingland KJ, Moore KE (1984) Effects of estradiol and prolactin on incertohypothalamic dopaminergic neurons in the male rat. Brain Res 323:83–91
Montorsi F, Perani D, Anchisi D, Salonia A, Scifo P, Rigiroli P, Zanoni M, Heaton JP, Rigatti P, Fazio F (2003) Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction. Int J Imp Res 15:203–209
Oliver C, Mical RS, Porter JC (1977) Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology 101:598–604
Paredes RG, Agmo A (2004) Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 73:179–226
Pi XJ, Grattan DR (1998) Differential expression of the two forms of prolactin receptor mRNA within microdissected hypothalamic nuclei of the rat. Brain Res Mol Brain Res 59:1–12
Robbins TW, Everitt BJ (1992) Functions of dopamine in the dorsal and ventral striatum. Sem Neurosci 4:119–128
Rosen RC, Lane RM, Menza M (1999) Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19:67–85
Rosen RC, Marin H (2003) Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 64 [Suppl 10]: 5–10
Rowland DL, Keeney C, Slob AK (2004) Sexual response in men with inhibited or retarded ejaculation. Int J Impot Res 16:270–274
Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC (1984) Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia an amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab 59:941–948
Schedlowski M, Hosch W, Oberbeck R, Benschop RJ, Jacobs R, Raab HR, Schmidt RE (1996) Catecholamines modulate human NK cell circulation and function via spleen-independent β2-adrenergic mechanisms. J Immunol 156:93–99
Shrenker P, Bartke A (1985) Adrenelectomy does not prevent the hyperprolactinemic induced sexual behavior deficits in CDF male rats. Life Sci 36:1881–1888
Sobrinho LG (1993) The psychogenic effects of prolactin. Acta Endocrinol 129:S38–40
Verhelst J, Abs R, Maiter D, Van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftpoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinaemia: a study in 455 patients. J Clin Endocr Metab 84:2518–2522
Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer J-P, Citrome L, McEvoy JP, Lieberman JA (2004) Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry 65:57–61
Walsh JP, Pullan PT (1997) Hyperprolactinaemia in males: a heterogeneous disorder. Aust N Z J Med 27:385–390
Walsh RJ, Slaby FJ, Posner BI (1987) A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid. Endocrinology 120:1864–1850
Acknowledgement
This article was supported by a grant by the Deutsche Forschungsgemeinschaft (DFG Sche 341/10-2)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krüger, T.H.C., Hartmann, U. & Schedlowski, M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol 23, 130–138 (2005). https://doi.org/10.1007/s00345-004-0496-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-004-0496-7